• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » UPDATE: Baxter recalls Vascu-Guard patches in FDA Class I recall

UPDATE: Baxter recalls Vascu-Guard patches in FDA Class I recall

June 4, 2015 By Fink Densford

 

baxter-1x1

UPDATED June 5, 2015, with details from the FDA.

Baxter (NYSE:BAX) said this week that it’s recalling its Vascu-Guard peripheral vascular patches packaged under 4 specific product codes. The company began notifying customers May 2.

The FDA has labeled it as a Class I recall, the most serious type of recall issued by the federal watch dog, which indicates that “there is a reasonable probability that use of these products will cause serious adverse health consequences or death.”

Deerfield Park, Ill.-based Baxter said it received complaints over the patches from customers who were unable to distinguish the smooth and rough surfaces of the patch as described in the instructions. The deviation is due to a new packaging configuration, the company said.

Incorrect orientation upon implantation, with the rough side towards the bloodstream, could increase the risk of vessel thrombosis and/or embolisms, the company said in a release published by the FDA.

The FDA added that the defect “may expose patients to significant health risks, including the movement of blood clots into the blood stream (embolism), reduced blood flow, stroke, organ failure, or death.”

The recalled codes are 1504026, 1504028, 1504030 and 1504032, covering 1x6cm, 0.8x8cm, 1x10cm and 2x9cm sizes of the Vascu-Guard.

New information from the FDA indicates that the recall affects 3,974 units distributed within the U.S. to 70 customers. The patches were manufactured between January 19 and May 1, 2015, and distributed between March 16 and May 1. No distribution outside the U.S. was indicated by the FDA.

The FDA said it has received 51 complaints related to the issue, and one serious injury. The Deerfield, Ill.-based healthcare giant said 1 incident included a postoperative thrombosis and stroke. Baxter said it will continue to investigate reports, but claims that no causal association with the patch has been established.

The company’s patch is designed to be used in vascular reconstruction, including carotid, renal, iliac, femoral, profund and tibial blood vessels and arteriovenous access revisions, Baxter said.

 

Filed Under: Food & Drug Administration (FDA), Recalls, Vascular Tagged With: Baxter, FDA

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy